Skoči na glavni sadržaj

Rad Hrvatske akademije znanosti i umjetnosti. Medicinske znanosti, Vol. 563 No. 66-67, 2024.

Pregledni rad

Specific reversal agents in acute stroke

Senta Frol orcid id orcid.org/0000-0001-9494-160X ; Dept of Vascular Neurology, University Medical Center Ljubljana, Ljubljana, Slovenia *

* Dopisni autor.

Puni tekst: engleski pdf 253 Kb

str. 72-76

preuzimanja: 59

citiraj

Sažetak

Direct oral anticoagulants (DOACs) are first line therapy in primary and secondary stroke prevention in patients with non-valvular atrial fibrillation. Regardless of their use a minority of patients still suffer acute stroke (ischemic or hemorrhagic). Specific reversal agents changed concept of therapy in DOAC-treated patients with acute stroke. In this manuscript data on randomized controlled trials, real-world evidence and proposed standard operating procedures are summarized.

Ključne riječi

specific reversal agents; acute stroke

Hrčak ID:

318619

URI

https://hrcak.srce.hr/318619

Datum izdavanja:

25.6.2024.

Posjeta: 135 *